PT  - JOURNAL ARTICLE
AU  - Biard, Marie
AU  - Detcheverry, Flavie E.
AU  - Betzner, William
AU  - Becker, Sara
AU  - Grewal, Karl S.
AU  - Azab, Sandi
AU  - Bloniasz, Patrick F.
AU  - Mazerolle, Erin L.
AU  - Phelps, Jolene
AU  - Smith, Eric E.
AU  - Badhwar, AmanPreet
TI  - Supporting decision-making for individuals living with dementia and their care partners with knowledge translation: an umbrella review
AID  - 10.1101/2024.09.17.24312581
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.09.17.24312581
4099  - http://medrxiv.org/content/early/2024/09/18/2024.09.17.24312581.short
4100  - http://medrxiv.org/content/early/2024/09/18/2024.09.17.24312581.full
AB  - Living with dementia requires decision-making about numerous topics including daily activities, such as advance care planning (ACP). Both individuals living with dementia and care partners require informed support for decision-making. We conducted an umbrella review to assess knowledge translation (KT) interventions supporting decision-making for individuals living with dementia and their informal care partners. Four databases were searched using 50 different search-terms, identifying 22 reviews presenting 32 KT interventions. The most common KT decision topic was ACP (N=21) which includes advanced care directives, feeding options, and placement in long-term care. The majority of KT interventions targeted care partners only (N=16), or both care partners and individuals living with dementia (N=13), with fewer interventions (N=3) targeting individuals living with dementia. Overall, our umbrella review offers insights into the beneficial impacts of KT interventions, such as increased knowledge and confidence, and decreased decisional conflicts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Vascular Training Platform (VAST) summer student project (2022, 2023) (M.B.); Fonds de Recherche Québec – Santé (FRQS) bourse de formation à la maîtrise (2021) and FRQS bourse de formation au doctorat (2024) (F.E.D.); VAST Health Research Training Program Doctoral Award and Canadian Consortium on Neurodegeneration in Aging (K.S.G.); VAST Postdoctoral fellowship (2022-2023) (S.A.); National Institutes of Health Training grant [PHS Grant number 1 T32 NS 131178-1, 2023-2024] (P.F.B.); VAST Health Research Training to Address Vascular Contributions to Cognitive Decline, Canadian Institutes of Health Research; Training Grant: Health Research Training Platform [RT0 179993] (E.L.M., E.E.S., and A.B.); Empowering Individuals at Risk for or Living with Vascular Cognitive Impairment: A Co-Developed Video Series Promoting Engagement, Prevention Strategies, and Self-Management; Canadian Institutes of Health Research Operating Grant: BHCIA: Knowledge Synthesis and Mobilization Grants – VCI [Funding number BK7 191189] (E.L.M., E.E.S., and A.B.); Enhancing Patient Engagement in the Vascular Contributions to Cognitive Decline Training Platform, Canadian Institutes of Health Research [SPOR, 2022-2024] (E.L.M., E.E.S., and A.B.); and FRQS Chercheurs boursiers Junior 1 (2020-2024) and the Fonds de soutien à la recherche pour les neurosciences du vieillissement from the Fondation Courtois (A.B.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript